Este sitio web utiliza tecnologías de seguimiento, como cookies, para brindar una mejor experiencia al usuario. Si continúa utilizando este sitio, entonces reconoce nuestro uso de tecnologías de seguimiento. Para obtener información adicional, consulte nuestra Política de Privacidad.
REGÍSTRESE
Bristol Myers Squibb has served as a strategic partner for the Cancer Research Institute by providing unparalleled support to advance scientific research and educate patients about immunotherapy.
Their collaboration has supported the first online patient portal focused on immunotherapy (TheAnswerToCancer.org), multi-year title sponsorship of the Answer to Cancer cycling events, Cancer Immunotherapy and You webinar series, and Immunotherapy Patient Summit series, including the Inaugural Patient Summit. Bristol Myers Squibb has also supported the CRI Irvington Postdoctoral Fellowship Program, and the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference.
In 2014, Bristol Myers Squibb’s leadership in the field of cancer immunotherapy was recognized with the Cancer Research Institute Oliver R. Grace Award, presented to Murdo Gordon, executive vice president and chief commercial officer, at the Cancer Research Institute Annual Awards Dinner.
Comuníquese con nosotros
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Directorio de Personal
Dr. Benjamin Vincent recaps highlights from Day 4 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference, covering cancer vaccines and innovative technologies to study tumor immunity.
Dr. E. John Wherry dicusses cell therapies and the cancer ecosystem during Day 3 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22).